This company has been marked as potentially delisted and may not be actively trading. DFP Healthcare Acquisitions (DFPH) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock DFPH vs. SHLT, ALMS, ENTA, LFVN, ACRS, CVRX, DERM, XGN, CGEN, and MOLNShould you be buying DFP Healthcare Acquisitions stock or one of its competitors? The main competitors of DFP Healthcare Acquisitions include SHL Telemedicine (SHLT), Alumis (ALMS), Enanta Pharmaceuticals (ENTA), Lifevantage (LFVN), Aclaris Therapeutics (ACRS), CVRx (CVRX), Journey Medical (DERM), Exagen (XGN), Compugen (CGEN), and Molecular Partners (MOLN). These companies are all part of the "medical" sector. DFP Healthcare Acquisitions vs. Its Competitors SHL Telemedicine Alumis Enanta Pharmaceuticals Lifevantage Aclaris Therapeutics CVRx Journey Medical Exagen Compugen Molecular Partners SHL Telemedicine (NASDAQ:SHLT) and DFP Healthcare Acquisitions (NASDAQ:DFPH) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, media sentiment, institutional ownership, analyst recommendations and profitability. Is SHLT or DFPH more profitable? SHL Telemedicine's return on equity of 0.00% beat DFP Healthcare Acquisitions' return on equity.Company Net Margins Return on Equity Return on Assets SHL TelemedicineN/A N/A N/A DFP Healthcare Acquisitions N/A -107.60%-1.47% Does the media favor SHLT or DFPH? In the previous week, SHL Telemedicine's average media sentiment score of 0.00 equaled DFP Healthcare Acquisitions'average media sentiment score. Company Overall Sentiment SHL Telemedicine Neutral DFP Healthcare Acquisitions Neutral Do insiders and institutionals have more ownership in SHLT or DFPH? 20.1% of SHL Telemedicine shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has higher earnings & valuation, SHLT or DFPH? SHL Telemedicine has higher revenue and earnings than DFP Healthcare Acquisitions. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSHL Telemedicine$55.94M0.60-$7.06MN/AN/ADFP Healthcare AcquisitionsN/AN/A-$8.34MN/AN/A Which has more risk & volatility, SHLT or DFPH? SHL Telemedicine has a beta of 0.11, meaning that its stock price is 89% less volatile than the S&P 500. Comparatively, DFP Healthcare Acquisitions has a beta of 0.03, meaning that its stock price is 97% less volatile than the S&P 500. SummarySHL Telemedicine beats DFP Healthcare Acquisitions on 6 of the 6 factors compared between the two stocks. Get DFP Healthcare Acquisitions News Delivered to You Automatically Sign up to receive the latest news and ratings for DFPH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DFPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DFPH vs. The Competition Export to ExcelMetricDFP Healthcare AcquisitionsOffices & Clinics Of Medical Doctors IndustryMedical SectorNASDAQ ExchangeMarket Cap$38.53M$33.61M$5.47B$8.93BDividend YieldN/AN/A5.32%4.14%P/E RatioN/AN/A26.2119.67Price / SalesN/A0.60387.56105.04Price / CashN/A54.0336.4056.84Price / Book-1.540.397.875.43Net Income-$8.34M-$7.06M$3.16B$249.20M DFP Healthcare Acquisitions Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DFPHDFP Healthcare AcquisitionsN/A$1.34flatN/AN/A$38.53MN/A0.00147,000SHLTSHL TelemedicineN/A$2.05flatN/AN/A$33.61M$55.94M0.00583ALMSAlumis3.6378 of 5 stars$3.01+7.5%$22.86+659.4%N/A$152.34MN/A0.00N/AHigh Trading VolumeENTAEnanta Pharmaceuticals3.9988 of 5 stars$7.32+2.8%$18.00+145.9%-42.2%$152.20M$67.64M-1.61160LFVNLifevantage4.0271 of 5 stars$12.24+1.4%$30.50+149.2%+97.7%$151.94M$200.16M17.74260News CoveragePositive NewsACRSAclaris Therapeutics2.4779 of 5 stars$1.52+9.4%$9.71+539.1%+33.6%$150.51M$18.72M-1.09100News CoverageAnalyst ForecastGap UpCVRXCVRx2.5192 of 5 stars$6.07+6.1%$14.50+138.9%-51.5%$149.14M$52.87M-2.78160DERMJourney Medical2.1317 of 5 stars$6.95+8.9%$9.88+42.1%+26.6%$148.63M$56.13M-17.8290News CoverageAnalyst UpgradeXGNExagen3.2773 of 5 stars$7.06+1.3%$7.50+6.2%+284.6%$148.46M$55.64M-8.40220High Trading VolumeCGENCompugen2.2748 of 5 stars$1.70+4.3%$4.00+135.3%-1.2%$145.46M$27.86M-10.6370MOLNMolecular Partners2.9022 of 5 stars$3.60-7.6%$12.00+233.8%-48.9%$144.54M$5.65M-1.87180 Related Companies and Tools Related Companies SHLT Competitors ALMS Competitors ENTA Competitors LFVN Competitors ACRS Competitors CVRX Competitors DERM Competitors XGN Competitors CGEN Competitors MOLN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DFPH) was last updated on 6/29/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DFP Healthcare Acquisitions Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share DFP Healthcare Acquisitions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
